ポナチニブの世界市場 2021年:メーカー別、地域別、種類・用途別

【英語タイトル】Global Ponatinib Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

GlobalInfoResearchが出版した調査資料(GIR21AR11223)・商品コード:GIR21AR11223
・発行会社(調査会社):GlobalInfoResearch
・発行日:2021年4月(※2024年版があります。お問い合わせください)
・ページ数:107
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2~3日)
・調査対象地域:グローバル
・産業分野:医療・医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
GlobalInfoResearch社の本調査レポートでは、ポナチニブの世界市場を広く調査・分析し、今後の市場展望をまとめております。ポナチニブの種類別市場規模(45mg、15mg)、用途別市場規模(CML、ALL)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(企業概要、製品概要、販売量、価格、売上):ARIAD Pharmaceuticals
・メーカー別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:45mg、15mg
・用途別分析2016年-2026年:CML、ALL
・ポナチニブの北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・ポナチニブのヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・ポナチニブのアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・ポナチニブの南米市場規模2016年-2026年:ブラジル、アルゼンチン
・ポナチニブの中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
【レポートの概要】

The Ponatinib market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Ponatinib size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Ponatinib market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Ponatinib market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
45mg
15mg

Market segment by Application can be divided into
CML
ALL

The key market players for global Ponatinib market are listed below:
ARIAD Pharmaceuticals

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

【レポートの目次】

1 Market Overview
1.1 Ponatinib Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Ponatinib Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 45mg
1.2.3 15mg
1.3 Market Analysis by Application
1.3.1 Overview: Global Ponatinib Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 CML
1.3.3 ALL
1.4 Global Ponatinib Market Size & Forecast
1.4.1 Global Ponatinib Sales in Value (2016-2026))
1.4.2 Global Ponatinib Sales in Volume (2016-2026)
1.4.3 Global Ponatinib Price by Type (2016-2026) & (USD/Unit)
1.5 Global Ponatinib Production Capacity Analysis
1.5.1 Global Ponatinib Total Production Capacity (2016-2026)
1.5.2 Global Ponatinib Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Ponatinib Market Drivers
1.6.2 Ponatinib Market Restraints
1.6.3 Ponatinib Trends Analysis
2 Manufacturers Profiles
2.1 ARIAD Pharmaceuticals
2.1.1 ARIAD Pharmaceuticals Details
2.1.2 ARIAD Pharmaceuticals Major Business
2.1.3 ARIAD Pharmaceuticals Ponatinib Product and Services
2.1.4 ARIAD Pharmaceuticals Ponatinib Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Ponatinib Sales by Manufacturer
3.1 Global Ponatinib Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Ponatinib Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Ponatinib
3.4 Market Concentration Rate
3.4.1 Top 3 Ponatinib Manufacturer Market Share
3.4.2 Top 6 Ponatinib Manufacturer Market Share
3.5 Global Ponatinib Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Ponatinib Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Ponatinib Market Size by Region
4.1.1 Global Ponatinib Sales in Volume by Region (2016-2026)
4.1.2 Global Ponatinib Revenue by Region (2016-2026)
4.2 North America Ponatinib Revenue (2016-2026)
4.3 Europe Ponatinib Revenue (2016-2026)
4.4 Asia-Pacific Ponatinib Revenue (2016-2026)
4.5 South America Ponatinib Revenue (2016-2026)
4.6 Middle East and Africa Ponatinib Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Ponatinib Sales in Volume by Type (2016-2026)
5.2 Global Ponatinib Revenue by Type (2016-2026)
5.3 Global Ponatinib Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Ponatinib Sales in Volume by Application (2016-2026)
6.2 Global Ponatinib Revenue by Application (2016-2026)
6.3 Global Ponatinib Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Ponatinib Sales by Type (2016-2026)
7.2 North America Ponatinib Sales by Application (2016-2026)
7.3 North America Ponatinib Market Size by Country
7.3.1 North America Ponatinib Sales in Volume by Country (2016-2026)
7.3.2 North America Ponatinib Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Ponatinib Sales by Type (2016-2026)
8.2 Europe Ponatinib Sales by Application (2016-2026)
8.3 Europe Ponatinib Market Size by Country
8.3.1 Europe Ponatinib Sales in Volume by Country (2016-2026)
8.3.2 Europe Ponatinib Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Ponatinib Sales by Type (2016-2026)
9.2 Asia-Pacific Ponatinib Sales by Application (2016-2026)
9.3 Asia-Pacific Ponatinib Market Size by Region
9.3.1 Asia-Pacific Ponatinib Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Ponatinib Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Ponatinib Sales by Type (2016-2026)
10.2 South America Ponatinib Sales by Application (2016-2026)
10.3 South America Ponatinib Market Size by Country
10.3.1 South America Ponatinib Sales in Volume by Country (2016-2026)
10.3.2 South America Ponatinib Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Ponatinib Sales by Type (2016-2026)
11.2 Middle East & Africa Ponatinib Sales by Application (2016-2026)
11.3 Middle East & Africa Ponatinib Market Size by Country
11.3.1 Middle East & Africa Ponatinib Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Ponatinib Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Ponatinib Typical Distributors
12.3 Ponatinib Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Ponatinib Revenue by Type, (USD Million), 2021-2026
Table 2. Global Ponatinib Revenue by Application, (USD Million), 2021-2026
Table 3. ARIAD Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 4. ARIAD Pharmaceuticals Major Business
Table 5. ARIAD Pharmaceuticals Ponatinib Product and Services
Table 6. ARIAD Pharmaceuticals Ponatinib Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Global Ponatinib Sales by Manufacturer (2019-2021e) & (K Units)
Table 8. Global Ponatinib Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 9. Market Position of Manufacturers in Ponatinib, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 10. Global Ponatinib Production Capacity by Company, (K Units): 2020 VS 2021
Table 11. Head Office and Ponatinib Production Site of Key Manufacturer
Table 12. Global Ponatinib Sales by Region (2016-2021e) & (K Units)
Table 13. Global Ponatinib Sales by Region (2021-2026) & (K Units)
Table 14. Global Ponatinib Revenue by Region (2016-2021e) & (USD Million)
Table 15. Global Ponatinib Revenue by Region (2021-2026) & (USD Million)
Table 16. Global Ponatinib Sales by Type (2016-2021e) & (K Units)
Table 17. Global Ponatinib Sales by Type (2021-2026) & (K Units)
Table 18. Global Ponatinib Revenue by Type (2016-2021e) & (USD Million)
Table 19. Global Ponatinib Revenue by Type (2021-2026) & (USD Million)
Table 20. Global Ponatinib Price by Type (2016-2021e) & (USD/Unit)
Table 21. Global Ponatinib Price by Type (2021-2026) & (USD/Unit)
Table 22. Global Ponatinib Sales by Application (2016-2021e) & (K Units)
Table 23. Global Ponatinib Sales by Application (2021-2026) & (K Units)
Table 24. Global Ponatinib Revenue by Application (2016-2021e) & (USD Million)
Table 25. Global Ponatinib Revenue by Application (2021-2026) & (USD Million)
Table 26. Global Ponatinib Price by Application (2016-2021e) & (USD/Unit)
Table 27. Global Ponatinib Price by Application (2021-2026) & (USD/Unit)
Table 28. North America Ponatinib Sales by Country (2016-2021e) & (K Units)
Table 29. North America Ponatinib Sales by Country (2021-2026) & (K Units)
Table 30. North America Ponatinib Revenue by Country (2016-2021e) & (USD Million)
Table 31. North America Ponatinib Revenue by Country (2021-2026) & (USD Million)
Table 32. North America Ponatinib Sales by Type (2016-2021e) & (K Units)
Table 33. North America Ponatinib Sales by Type (2021-2026) & (K Units)
Table 34. North America Ponatinib Sales by Application (2016-2021e) & (K Units)
Table 35. North America Ponatinib Sales by Application (2021-2026) & (K Units)
Table 36. Europe Ponatinib Sales by Country (2016-2021e) & (K Units)
Table 37. Europe Ponatinib Sales by Country (2021-2026) & (K Units)
Table 38. Europe Ponatinib Revenue by Country (2016-2021e) & (USD Million)
Table 39. Europe Ponatinib Revenue by Country (2021-2026) & (USD Million)
Table 40. Europe Ponatinib Sales by Type (2016-2021e) & (K Units)
Table 41. Europe Ponatinib Sales by Type (2021-2026) & (K Units)
Table 42. Europe Ponatinib Sales by Application (2016-2021e) & (K Units)
Table 43. Europe Ponatinib Sales by Application (2021-2026) & (K Units)
Table 44. Asia-Pacific Ponatinib Sales by Region (2016-2021e) & (K Units)
Table 45. Asia-Pacific Ponatinib Sales by Region (2021-2026) & (K Units)
Table 46. Asia-Pacific Ponatinib Revenue by Region (2016-2021e) & (USD Million)
Table 47. Asia-Pacific Ponatinib Revenue by Region (2021-2026) & (USD Million)
Table 48. Asia-Pacific Ponatinib Sales by Type (2016-2021e) & (K Units)
Table 49. Asia-Pacific Ponatinib Sales by Type (2021-2026) & (K Units)
Table 50. Asia-Pacific Ponatinib Sales by Application (2016-2021e) & (K Units)
Table 51. Asia-Pacific Ponatinib Sales by Application (2021-2026) & (K Units)
Table 52. South America Ponatinib Sales by Country (2016-2021e) & (K Units)
Table 53. South America Ponatinib Sales by Country (2021-2026) & (K Units)
Table 54. South America Ponatinib Revenue by Country (2016-2021e) & (USD Million)
Table 55. South America Ponatinib Revenue by Country (2021-2026) & (USD Million)
Table 56. South America Ponatinib Sales by Type (2016-2021e) & (K Units)
Table 57. South America Ponatinib Sales by Type (2021-2026) & (K Units)
Table 58. South America Ponatinib Sales by Application (2016-2021e) & (K Units)
Table 59. South America Ponatinib Sales by Application (2021-2026) & (K Units)
Table 60. Middle East & Africa Ponatinib Sales by Country (2016-2021e) & (K Units)
Table 61. Middle East & Africa Ponatinib Sales by Country (2021-2026) & (K Units)
Table 62. Middle East & Africa Ponatinib Revenue by Country (2016-2021e) & (USD Million)
Table 63. Middle East & Africa Ponatinib Revenue by Country (2021-2026) & (USD Million)
Table 64. Middle East & Africa Ponatinib Sales by Type (2016-2021e) & (K Units)
Table 65. Middle East & Africa Ponatinib Sales by Type (2021-2026) & (K Units)
Table 66. Middle East & Africa Ponatinib Sales by Application (2016-2021e) & (K Units)
Table 67. Middle East & Africa Ponatinib Sales by Application (2021-2026) & (K Units)
Table 68. Direct Channel Pros & Cons
Table 69. Indirect Channel Pros & Cons
Table 70. Ponatinib Typical Distributors
Table 71. Ponatinib Typical Customers
List of Figures
Figure 1. Ponatinib Picture
Figure 2. Global Ponatinib Sales Market Share by Type in 2020
Figure 3. 45mg
Figure 4. 15mg
Figure 5. Global Ponatinib Sales Market Share by Application in 2020
Figure 6. CML
Figure 7. ALL
Figure 8. Global Ponatinib Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 9. Global Ponatinib Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. United States Ponatinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 11. Canada Ponatinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Mexico Ponatinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Germany Ponatinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. France Ponatinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. United Kingdom Ponatinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Russia Ponatinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Italy Ponatinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. China Ponatinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Japan Ponatinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Korea Ponatinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. India Ponatinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Southeast Asia Ponatinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Australia Ponatinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Brazil Ponatinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Egypt Ponatinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Saudi Arabia Ponatinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. South Africa Ponatinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Turkey Ponatinib Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Global Ponatinib Sales (2016-2026) & (K Units)
Figure 30. Global Ponatinib Production Capacity (2016-2026) & (K Units)
Figure 31. Global Ponatinib Production Capacity by Geographic Region: 2020 VS 2021
Figure 32. Ponatinib Market Drivers
Figure 33. Ponatinib Market Restraints
Figure 34. Ponatinib Market Trends
Figure 35. Global Ponatinib Sales Market Share by Manufacturer in 2020
Figure 36. Global Ponatinib Revenue Market Share by Manufacturer in 2020
Figure 37. Ponatinib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 38. Top 3 Ponatinib Manufacturer (Revenue) Market Share in 2020
Figure 39. Top 6 Ponatinib Manufacturer (Revenue) Market Share in 2020
Figure 40. Global Ponatinib Sales Market Share by Region (2016-2026)
Figure 41. Global Ponatinib Revenue Market Share by Region (2016-2026)
Figure 42. North America Ponatinib Revenue (2016-2026) & (USD Million)
Figure 43. Europe Ponatinib Revenue (2016-2026) & (USD Million)
Figure 44. Asia-Pacific Ponatinib Revenue (2016-2026) & (USD Million)
Figure 45. South America Ponatinib Revenue (2016-2026) & (USD Million)
Figure 46. Middle East & Africa Ponatinib Revenue (2016-2026) & (USD Million)
Figure 47. Global Ponatinib Sales Market Share by Type (2016-2026)
Figure 48. Global Ponatinib Revenue Market Share by Type (2016-2026)
Figure 49. Global Ponatinib Price by Type (2016-2026) & (USD/Unit)
Figure 50. Global Ponatinib Sales Market Share by Application (2016-2026)
Figure 51. Global Ponatinib Revenue Market Share by Application (2016-2026)
Figure 52. Global Ponatinib Price by Application (2016-2026) & (USD/Unit)
Figure 53. North America Ponatinib Sales Market Share by Country (2016-2026)
Figure 54. North America Ponatinib Revenue Market Share by Country (2016-2026)
Figure 55. North America Ponatinib Sales Market Share by Type (2016-2026)
Figure 56. North America Ponatinib Sales Market Share by Application (2016-2026)
Figure 57. Europe Ponatinib Sales Market Share by Country (2016-2026)
Figure 58. Europe Ponatinib Revenue Market Share by Country (2016-2026)
Figure 59. Europe Ponatinib Sales Market Share by Type (2016-2026)
Figure 60. Europe Ponatinib Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific Ponatinib Sales Market Share by Region (2016-2026)
Figure 62. Asia-Pacific Ponatinib Revenue Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Ponatinib Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Ponatinib Sales Market Share by Application (2016-2026)
Figure 65. South America Ponatinib Sales Market Share by Country (2016-2026)
Figure 66. South America Ponatinib Revenue Market Share by Country (2016-2026)
Figure 67. South America Ponatinib Sales Market Share by Type (2016-2026)
Figure 68. South America Ponatinib Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Ponatinib Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Ponatinib Revenue Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Ponatinib Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Ponatinib Sales Market Share by Application (2016-2026)
Figure 73. Sales Channel: Direct Channel vs Indirect Channel
Figure 74. Methodology
Figure 75. Research Process and Data Source


【掲載企業】

ARIAD Pharmaceuticals

★調査レポート[ポナチニブの世界市場 2021年:メーカー別、地域別、種類・用途別] (コード:GIR21AR11223)販売に関する免責事項を必ずご確認ください。
★調査レポート[ポナチニブの世界市場 2021年:メーカー別、地域別、種類・用途別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆